Polar Asset Management Partners’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-678,918
| Closed | -$6.85M | – | 1252 |
|
|
2022
Q4 | $6.85M | Hold |
678,918
| – | – | 0.08% | 299 |
|
|
2022
Q3 | $6.73M | Hold |
678,918
| – | – | 0.08% | 353 |
|
|
2022
Q2 | $6.66M | Buy |
678,918
+178,918
| +36% | +$1.76M | 0.08% | 347 |
|
|
2022
Q1 | $4.91M | Hold |
500,000
| – | – | 0.05% | 417 |
|
|
2021
Q4 | $4.86M | Hold |
500,000
| – | – | 0.05% | 391 |
|
|
2021
Q3 | $4.85M | Hold |
500,000
| – | – | 0.05% | 376 |
|
|
2021
Q2 | $4.84M | Buy |
+500,000
| New | +$4.84M | 0.05% | 370 |
|